These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26738328)

  • 61. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
    Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
    Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
    [TBL] [Abstract][Full Text] [Related]  

  • 62. General effect of low-dose tamsulosin (0.2 mg) as a first-line treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia: a systematic review and meta-analysis.
    Shim SR; Kim JH; Choi H; Lee WJ; Kim HJ; Bae MY; Hwang SD; Kim KH; Bae JH; Yoon SJ
    Curr Med Res Opin; 2015 Feb; 31(2):353-65. PubMed ID: 25350225
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Efficacy and safety of Tonglin Powder in the treatment of benign prostatic hyperplasia].
    Sun JM; Liu P; Han WJ
    Zhonghua Nan Ke Xue; 2016 Oct; 22(10):897-901. PubMed ID: 29278471
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical study on Kangquan Recipe (康泉方) for benign prostatic hyperplasia patients: a randomized controlled trial.
    Huang YP; Wen YH; Wu GH; Hong ZF; Xu SW; Peng AX
    Chin J Integr Med; 2014 Dec; 20(12):949-54. PubMed ID: 25428342
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of doxazosin gastrointestinal therapeutic system 4 mg vs tamsulosin 0.2 mg on nocturia in Chinese men with lower urinary tract symptoms: a prospective, multicenter, randomized, open, parallel study.
    Zhang K; Yu W; Jin J; Ye H; Wang X; Zhang N; Yang Y; Zhong C; Wan B
    Urology; 2011 Sep; 78(3):636-40. PubMed ID: 21696807
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates.
    Wang M; Guo L; Duan F; Yuan K; Zhang G; Li K; Yan J; Wang Y; Kang H
    BJU Int; 2016 Jan; 117(1):155-64. PubMed ID: 25851432
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tamsulosin versus transurethral resection of the prostate: effect on nocturia as a result of benign prostatic hyperplasia.
    Simaioforidis V; Papatsoris AG; Chrisofos M; Chrisafis M; Koritsiadis S; Deliveliotis C
    Int J Urol; 2011 Mar; 18(3):243-8. PubMed ID: 21332817
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.
    Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Nandy I; Morrill BB; Gagnier RP; Montorsi F;
    Eur Urol; 2010 Jan; 57(1):123-31. PubMed ID: 19825505
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative rapid onset of efficacy between doxazosin gastrointestinal therapeutic system and tamsulosin in patients with lower urinary tract symptoms from benign prostatic hyperplasia: a multicentre, prospective, randomised study.
    Chung MS; Lee SH; Park KK; Yoo SJ; Chung BH
    Int J Clin Pract; 2011 Nov; 65(11):1193-9. PubMed ID: 21995695
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Clinical effectiveness and safety study of combined therapy with an alpha-blocker and an anticholinergic for patients with LUT/BPH].
    Xiao H; Li HZ; Yang Y; Huang ZM; Li YQ; Zhao XF
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1590-3. PubMed ID: 17803845
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment satisfaction with tadalafil or tamsulosin vs placebo in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH): results from a randomised, placebo-controlled study.
    Oelke M; Giuliano F; Baygani SK; Melby T; Sontag A
    BJU Int; 2014 Oct; 114(4):568-75. PubMed ID: 24612148
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Efficacy of electroacupuncture in treating 93 patients with benign prostatic hyperplasia].
    Yang T; Zhang XQ; Feng YW
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Nov; 28(11):998-1000. PubMed ID: 19213342
    [TBL] [Abstract][Full Text] [Related]  

  • 73. How much improvement is needed for a real difference of lower urinary tract symptoms after long-term combination therapy for benign prostatic hyperplasia.
    Jiang YH; Liao CH; Kuo HC
    Int J Clin Pract; 2014 Sep; 68(9):1081-6. PubMed ID: 24673775
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tamsulosin for benign prostatic hyperplasia.
    Wilt TJ; Mac Donald R; Rutks I
    Cochrane Database Syst Rev; 2003; (1):CD002081. PubMed ID: 12535426
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tamsulosin and Solifenacin in the Treatment of Benign Prostatic Hyperplasia in combination with overactive bladder.
    Wang H; Chang Y; Liang H
    Pak J Med Sci; 2017; 33(4):988-992. PubMed ID: 29067079
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Clinical effectiveness and safety of combined therapy with an alpha-blocker and an anticholinergic drug for patients with benign prostatic hyperplasia].
    Xiao H; Li HZ; Huang ZM; Li YQ
    Zhonghua Wai Ke Za Zhi; 2010 Dec; 48(23):1771-3. PubMed ID: 21211380
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy and Tolerability of Tamsulosin 0.4 mg in Patients with Symptomatic Benign Prostatic Hyperplasia.
    Chung JW; Choi SH; Kim BS; Kim TH; Yoo ES; Kim CI; Lee KS; Kwon TG
    Korean J Urol; 2011 Jul; 52(7):479-84. PubMed ID: 21860769
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN).
    Van Kerrebroeck P; Haab F; Angulo JC; Vik V; Katona F; Garcia-Hernandez A; Klaver M; Traudtner K; Oelke M
    Eur Urol; 2013 Sep; 64(3):398-407. PubMed ID: 23537687
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tamsulosin Treatment Affecting Patient-reported Outcomes in Benign Prostatic Hyperplasia-associated Depressive Symptoms.
    Kim KS; Jang EY; Kim YT; Moon HS
    Urology; 2016 Jan; 87():172-7. PubMed ID: 26525959
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Efficacy of Lamiophlomis Rotata Capsule in the treatment of type ⅢB prostatitis].
    Wei ZF; Zhou K; Dong J; Fu D; Xu XF; Li P; Cheng W; Zhang ZY
    Zhonghua Nan Ke Xue; 2017 Dec; 23(12):1107-1110. PubMed ID: 29738183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.